Data de publicação: 14/05/2020 - 14:19
A research led by the Oswaldo Cruz Institute (IOC/Fiocruz) points out that the circulation of the novel coronavirus (SARS-CoV-2) started up to four weeks before the first cases were registered in countries in Europe and the Americas. The study, which uses a statistical methodology of inference from death records, indicates that, while countries were monitoring travelers and confirming the first imported Covid-19 cases, community transmission of...
Notícias
Data de publicação: 29/04/2020 - 12:19
Published in the JAMA Network Open, the initial results of the CloroCovid-19 trial show that patients with severe Covid-19 should not take high doses of chloroquine. The trial, whose goal is to assess the efficacy of two different dosages of the drug and has analised 81 patients with SARS (severe acute respiratory syndrome), is being led by more than 70 researchers, post-graduation students, and collaborators from renowned scientific...
Notícias
Data de publicação: 04/08/2020 - 10:54
Many of us have greatly been affected by Covid-19 - from loss of jobs, closure of schools, travel bans, movement restriction and much more. However, some groups of people have been more affected other than others, and the more vulnerable in the community, societies and groups have borne the greatest brunt. The disease has affected men, women and people of other genders differently.
Various questions and concerns were raised during a...
Notícias
Data de publicação: 03/08/2020 - 13:49
Researchers from the Oswaldo Cruz Foundation develop a plan to support the fight against Covid-19 among indigenous peoples. One of the goals is to intensify surveillance and improve information about the impacts of the pandemic on these populations, through six lines of action. The initiative mobilized different units and vice-presidencies and was highlighted by the president of Fiocruz, Nísia Trindade Lima. “This is a joint action...
Notícias
Data de publicação: 27/07/2020 - 17:33
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) and by the Federal University of Juiz de Fora (UFJF), in collaboration with hospitals and research centers in Rio de Janeiro, provides new information that helps understand one of the most severe and frequent complications observed in Covid-19 patients hospitalized in intensive care units (ICUs). Published in “Blood”, the main international scientific journal in the area of...
Notícias
Data de publicação: 15/07/2020 - 11:30
Originally published at Reports in Public Health
In 2020, the COVID-19 pandemic has plunged nearly the entire planet into a health and humanitarian crisis, testing the human species in various dimensions. So many doubts raise the following question: is COVID-19 an inevitable phenomenon, given the relationship humans have with the various ecosystems and the other animal and plant species? Or in a simplified approach, is COVID-19 the episodic (...
Notícias
Data de publicação: 14/07/2020 - 12:13
Fiocruz president, Nísia Trindade Lima, is one of the members of the Lancet Covid-19 Commission. Led by American economist Jeffrey Sachs, the commission is an interdisciplinary initiative that includes leaders in health sciences, business, finances, and public policies, to formulate recommendations to overcome the challenges brought by the pandemic.
“The Commission was created to help speed up global, equitable, and long...
Notícias
Data de publicação: 14/07/2020 - 11:56
With the goal of better understanding the beginning of the novel coronavirus pandemic in Brazil, researchers of the Oswaldo Cruz Foundation (Fiocruz) have carried out a wide genetic study involving almost a hundred samples from patients from all Brazilian regions, infected by the SARS-CoV-2 virus in the early moments of the pandemic in national territory.
The study was led by specialists of the Respiratory Viruses and Measles Laboratory,...
Notícias
Data de publicação: 13/07/2020 - 17:18
Deaths in the city of Rio de Janeiro have increased by 64% in ths months of April and May 2020, when compared to the average in this same period in the last 3 years. In addition, a detailed analysis of the records shows a disturbing figure: deaths out of hospitals (both in health units, clinics, and other basic healthcare venues and at home) have practically doubled. This may be an indicator that, early in the epidemic, the city’s hospital...
Notícias
Data de publicação: 11/09/2020 - 12:22
Researchers of Fiocruz and Visuri, reference institutions in research and development of technology for health, have developed a portable device, the OmniLAMP, for the molecular diagnosis of COVID-19 through the detection of SARS-CoV-2 genetic material. Using the RT-LAMP technique, which transforms RNA into DNA and amplifies it isothermically, the equipment makes it possible to run tests with safety levels similar to those of the PCR (polymerase...
Notícias
Data de publicação: 25/08/2020 - 15:19
The Oswaldo Cruz Foundation (Fiocruz), in a partnership with the Community Council of Manguinhos, Redes da Maré, Dados do Bem, SAS Brasil and União Rio, is launching an innovative project that makes possible full healthcare in the favelas, and will contribute to face the Covid-19 pandemic in the communities of Maré and Manguinhos, in Rio de Janeiro. Conexão Saúde: de olho na Covid (Health Connection: keeping an...
Notícias
Data de publicação: 25/08/2020 - 13:53
The new coronavirus pandemic has been posing unheard-of challenges to health information systems. Covid-19 data in Brazil, both at a state and municipal level, are crucial for the decision making on public policies and emergency measures to contain the pandemic. These data, however, depend on systems and panels whose coverage and quality vary wildly all over the country. This is the conclusion of a Fiocruz paper, which states that the release of...
Notícias
Data de publicação: 24/09/2020 - 12:47
An international project, of which Fiocruz Pernambuco is part, is evaluating public health response to Covid-19 in Brazil, Canada, China, France, and Mali. Researchers will compare data obtained in the five countries, to identify the strong and weak points of the measures adopted, including the challenges faced by health professionals and health systems. The goal is to gather the lessons learned, based on strict interdisciplinary researches...
Notícias
Data de publicação: 24/09/2020 - 12:17
In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The trial, which was initially expected to be carried out only in the state of Mato Grosso do Sul, will be expanded to the state of Rio de Janeiro.
Coordinated in Brazil by Fiocruz...
Notícias
Data de publicação: 26/10/2020 - 14:33
Two projects with the participation of Fiocruz will be receiving financial support from the United Kingdom, after being acknowledged by the Global Effort on Covid-19 (GECO) Health Research. The call sought research projects that focused on offering responses to the multiple health consequences of the pandemic in low- and medium-income rate countries. Announced on October 10, the GECO is financed by two British research institutions, the National...
Notícias
Data de publicação: 13/10/2020 - 14:44
The Center for Technological Development in Health of the Oswaldo Cruz Foundation (CDTS/Fiocruz) and the European Infrastructure for Translational Medicine (Eatris) signed, in September, a letter of intent with the goal of promoting initiatives in translational sciences. The partnership includes not only education and training projects within this theme, but also the creation of a Global Hub of Drug Repositioning, with an initial focus on...
Notícias
Data de publicação: 07/10/2020 - 17:44
In a partnership with the National Institute of Metrology, Quality, and Technology (Inmetro), researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) have recorded new images that reveal the effects of the infection by the new coronavirus in the cells. Obtained through high-resolution microscopy, the photographs show that infected cells show membrane extensions, called filopodia, that form intercellular connections. This alteration may be one of...
Notícias
Data de publicação: 07/10/2020 - 16:55
Genetic sequences and clinical and epidemiological data of influenza and SARS-CoV-2 viruses. Geographical and specific data of species associated with avian viruses and viruses of other animals. These contents, crucial to help national and international researchers understand more rapidly how the viruses evolve and spread during epidemics and pandemics, can be found in the international platform of genomic data, the GISAID. Since the beginning...
Notícias
Data de publicação: 07/10/2020 - 15:41
In a cooperation between Fiocruz Pernambuco, the Central Laboratory of Public Health of Pernambuco (Lacen/SES-PE) and the University of Pernambuco Campus Serra Talhada (UPE-ST), a pioneer study describes the clinical and epidemiological characteristics of the first 557 patients of the state to be contaminated by the new coronavirus (SARS-CoV-2). The paper was published (29/9) in the international magazine Travel Medicine and Infectious...
Notícias
Data de publicação: 29/09/2020 - 10:54
In a partnership with Instituto D’Or (Idor) and the Federal University of Rio de Janeiro (UFRJ), a study by the Center for Technological Development in Health (CDTS/Fiocruz) observed that the virus responsible for the Covid-19 pandemic, the SARS-CoV-2, can infect neural cells and create brain damage. Organized by Faperj and published in preprint, the project started with the analysis of the neural tissue of a patient who died due to...
Notícias
Data de publicação: 16/12/2020 - 16:31
The Oswaldo Cruz Foundation, through the Institute of Technology in Immunobiologicals (Bio-Manguinhos), signed with the Government of the State of Rio de Janeiro, this Thursday (3/12), the final deed of the land where the Industrial Complex of Biotechnology in Health (Cibs) is being built, in the Industrial District of Santa Cruz, in Rio de Janeiro. The ceremony took place at the Guanabara Palace, the head office of the Rio de Janeiro government...
Notícias
Data de publicação: 06/11/2020 - 10:35
To mark the six months of Covid-19 in Brazil, the Oswaldo Cruz Foundation (Fiocruz) has published a special edition of its Covid-19 Observatory Bulletin with an assessment of the pandemic that has been having effects on the health of populations and challenging science all over the world. Made by a multidisciplinary team of researchers of the Foundation, the investigation includes the main aspects related to Covid-19, such as social, economic,...
Notícias
Data de publicação: 03/11/2020 - 15:45
On October 26th the Oswaldo Cruz Foundation (Fiocruz) sent to the External Commission of the House of Representatives for the Fight Against Covid-19 the Technological Order Agreement signed with AstraZeneca for the production of a Covid-19 vaccine. Although the contract contains classified information, common in contracts of this nature and classified according to Brazilian law, the document was sent to the Commission in its full version...
Notícias
Data de publicação: 03/11/2020 - 14:46
Symptoms of anxiety and depression affect 47.3% of essential workers during the Covid-19 pandemic, in Brazil and in Spain. More than half of them - and 27.4% of the total of people interviewed - suffer from both anxiety and depression simultaneously. In addition, 44.3% report alcohol abuse; 42.9% report changes in their sleep habits; and 30.9% were diagnosed with or were treated for mental illness in the year prior to a survey coordinated by...
Notícias
Data de publicação: 06/08/2020 - 12:28
Covid-19 has shown Brazil’s fragility in promoting an industrial policy in the health area: facing the pandemic involves prevention, services preparation, drugs, equipment, diagnostic tests, and the future vaccine. When one of these parts fails the entire strategy to contain the disease’s expansion will be jeopardized. This is Carlos Gadelha’s evaluation, a researcher and coordinator of Prospection Actions at Fiocruz. “...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
